After One Skin Cancer, the Odds of Another

If you've had one skin cancer, are you likely to get another?

Having had one skin cancer does raise your chances of a second, and the reason is straightforward: the main cause usually has not gone anywhere. Ultraviolet light from the sun and from tanning beds is the leading modifiable cause of skin cancer, and it damages the whole field of skin it reaches, not just the spot that became a tumor 1Ref 1National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.Ultraviolet exposure from sun and tanning beds is the leading modifiable cause of skin cancer, and continued exposure and indoor tanning are the risk factors most worth reducing.. So the same sun-exposed skin that produced the first cancer carries the same risk across its surface. A personal history of skin cancer is, for that reason, one of the strongest signals that regular skin surveillance is worth it.

This holds across the common types. The sun damage behind a basal cell or squamous cell carcinoma sits across the surrounding skin as well, so new keratinocyte cancers can appear over the years, and someone treated for melanoma is followed for both new melanomas and other skin cancers. The point is not to frighten you — it is that a second cancer, found early, is usually very treatable.

A cancer that comes back vs. a brand-new one

Two different things get blended together under 'getting it again,' and they are worth separating. A recurrence is the original cancer regrowing at the same site, usually because a few cells were left behind. A second primary is an entirely new cancer somewhere else on the skin. Complete removal is what addresses the first: for melanoma, guidelines call for excising the tumor with a margin of normal skin sized to how deep the tumor went 2Ref 2Swetter SM, Tsao H, Bichakjian CK, et al. (2019).Guidelines of care for the management of primary cutaneous melanoma.Primary melanoma is treated by surgical excision with margins sized to tumor thickness; complete removal is what addresses recurrence at the original site..

A recurrence is the same tumor regrowing at its original site; a second primary is a new, separate cancer elsewhere.

The risk of a local recurrence is part of why some tumors are removed with margin-controlled surgery. Mohs micrographic surgery is considered appropriate for tumors with high-risk features or in high-risk anatomic locations, where checking the edges under the microscope during the operation lowers the chance that cancer is left behind 3Ref 3Ad Hoc Task Force (Connolly SM, Baker DR, Coldiron BM, et al.) (2012).AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery.Mohs micrographic surgery is rated appropriate for tumors with high-risk features or in high-risk anatomic locations, where intraoperative margin control lowers the chance of leaving cancer behind.. Preventing a new primary elsewhere is a different job — that one is about protecting and watching the rest of your skin.

What pushes the risk of another cancer up

The biggest lever is the one you already know: cumulative ultraviolet exposure. Sun and tanning beds keep adding damage to skin that is already primed, which is why continued unprotected exposure and indoor tanning are the risk factors most worth changing 1Ref 1National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.Ultraviolet exposure from sun and tanning beds is the leading modifiable cause of skin cancer, and continued exposure and indoor tanning are the risk factors most worth reducing.. Other factors are fixed but still shape how closely you are watched.

• Skin type. Very fair skin that burns rather than tans, freckling, light eyes, and red or blond hair are part of the picture clinicians weigh — the pattern behind fair skin cancer risk.
• Immune status. Long-term immune suppression, including the medication taken after an organ transplant, is one reason some people are followed more closely; skin cancer risk after an organ transplant is high enough that transplant teams often build in routine dermatology checks.
• Prior cancers. Having had more than one skin cancer, or a more aggressive one, generally means closer surveillance.

Your dermatologist weighs these together to set how often you are seen.

What actually lowers the risk of a new skin cancer

The most reliable lever is reducing ultraviolet exposure going forward, and there is trial evidence behind it. In a long-term randomized study, adults who applied sunscreen daily developed fewer melanomas — including fewer invasive melanomas — than those who used it only when they felt like it 4Ref 4Green AC, Williams GM, Logan V, Strutton GM (2011).Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up.Adults who used sunscreen daily developed fewer melanomas, including fewer invasive melanomas, than those who used it discretionarily in a long-term randomized trial.. Broad protection works the same way: shade in the middle of the day, clothing and a hat, and avoiding tanning beds all reduce the ultraviolet dose that drives new cancers 1Ref 1National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.Ultraviolet exposure from sun and tanning beds is the leading modifiable cause of skin cancer, and continued exposure and indoor tanning are the risk factors most worth reducing..

None of this reverses old damage, and no habit drops the risk to zero, which is why prevention and surveillance run together. Sun protection lowers how many new cancers form; regular skin checks catch the ones that still do, while they are small.

How people with a history are followed

After a skin cancer, most people move from occasional self-checks into a set schedule with a dermatologist — the interval depends on the type, how advanced it was, and personal risk. This is surveillance of a known-higher-risk person, which is different from screening the general public: for symptom-free adults with no history, the US Preventive Services Task Force found the evidence insufficient to weigh the benefits and harms of routine whole-body visual screening 5Ref 5US Preventive Services Task Force (2023).Skin Cancer: Screening.For asymptomatic adults with no history, the USPSTF found the evidence insufficient to weigh the benefits and harms of routine whole-body visual screening; the recommendation does not address people with a prior skin cancer., and that recommendation explicitly does not speak to following someone who has already had a skin cancer.

Between visits, monthly self-exams and photographs of any watch-and-wait spots are the usual advice, and it is reasonable to ask what your own skin check frequency should be. If you want a refresher on who should get regular skin checks and how often, that is a fair question to bring to the appointment. Cost should not be the wall it can feel like — community events and free skin cancer screening programs exist in many areas.

Why finding a second one early matters so much

Early detection is the entire payoff of surveillance, because outcomes track closely with how early a cancer is caught. For melanoma, five-year relative survival is very high when it is found while still confined to the skin, and it falls once the disease has spread to nearby nodes or beyond 6Ref 6National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.Five-year relative survival for melanoma is high when the disease is localized to the skin and lower once it has spread to regional nodes or distant sites.. Basal and squamous cell carcinomas are rarely life-threatening but are far simpler to treat when small.

That is the case for staying engaged rather than anxious. A history of skin cancer is not a verdict that another is coming — it is a reason to keep a light, steady watch, protect your skin, and keep the appointments, so that if a second cancer ever does appear, it is found at the stage where treatment is easiest.